Understanding how certain proteins ensure the accuracy of genetic code translation
Translational quality control by trans-editing domains
This study looks at how certain proteins help make sure that the building blocks of life, called amino acids, are correctly attached to their helpers, called tRNA, to prevent mistakes in making proteins, which could lead to health problems, and the findings might help develop new treatments for diseases caused by these mistakes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11074094 on NIH RePORTER |
What this research studies
This research investigates the role of aminoacyl-tRNA synthetases (ARSs) in maintaining the accuracy of protein synthesis by attaching amino acids to their corresponding tRNA. It focuses on the proofreading functions of these enzymes, which help to correct errors that could lead to toxic effects in cells. By studying the mechanisms of trans-editing domains, the research aims to uncover how these proteins contribute to quality control in translation, particularly under varying environmental conditions. Patients may benefit from insights gained about cellular processes that could lead to new therapeutic strategies for diseases caused by mistranslation.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with genetic disorders related to protein synthesis errors.
Not a fit: Patients with conditions unrelated to aminoacyl-tRNA synthetase function may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for conditions caused by errors in protein synthesis.
How similar studies have performed: Previous research has shown promising results in understanding the proofreading mechanisms of aminoacyl-tRNA synthetases, indicating that this area of study has potential for significant advancements.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Musier-Forsyth, Karin M — Ohio State University
- Study coordinator: Musier-Forsyth, Karin M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.